Back to search
FDAFDA · Food and drugs·Recall number D-163-2013

Lac-Hydrin (ammonium lactate) Cream, 12%, packaged in a) 280 g (2 x 140 g tubes), NDC 10631-099-28; b) 385 g bottle, NDC 10631-099-38; Rx only, Ranbaxy, Jacksonville, FL 32257 USA.

Published February 20, 2013 · Recall initiated: December 27, 2012

Summary

FDA records drug Class III recall D-163-2013, published February 20, 2013 and initiated December 27, 2012. Recalling firm: Ranbaxy Inc.; Status: Terminated; Reported quantity: 6,535 tubes and bottles; Lot: Lot #: RB91881, Exp 07/14; RB91891, Exp 07/13. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Crystallization: Recall is due to a non-characteristic gritty/sandy texture to the product which is likely due to some crystallization of the product.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Ranbaxy Inc.
Distributor
Nationwide and Puerto Rico
Lot
Lot #: RB91881, Exp 07/14; RB91891, Exp 07/13
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Lac-Hydrin (ammonium lactate) Cream, 12%, packaged in a) 280 g (2 x 140 g tubes), NDC 10631-099-28; b) 385 g bottle, NDC 10631-099-38; Rx only, Ranbaxy, Jacksonville, FL 32257 USA. recalled?

Yes. FDA published recall D-163-2013 on February 20, 2013. Reported hazard: Crystallization: Recall is due to a non-characteristic gritty/sandy texture to the product which is likely due to some crystallization of the product.

What should I do if I have this product?

Voluntary: Firm initiated · Letter